Annovis Bio Inc/ US03615A1088 /
| 2024-05-03 10:10:00 PM | Chg. -0.27 | Volume | Bid2:00:00 AM | Ask2:00:00 AM | High | Low |
|---|---|---|---|---|---|---|
| 5.18USD | -4.95% | 609,601 Turnover: 2.79 mill. |
5.19Bid Size: 900 | 5.33Ask Size: 100 | 5.73 | 4.86 |
GlobeNewswire
04-29
Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer’s...
GlobeNewswire
04-02
Annovis Bio Provides Corporate Updates and Reports Fourth Quarter and Full Year 2023 Financial Resul...
GlobeNewswire
04-01
Annovis Announces Publication That Supports Understanding of Buntanetap’s Mechanism of Action in Hum...
GlobeNewswire
03-20
Annovis Bio Provides Data Announcement Update for the Phase II/III Study of Buntanetap in Alzheimer’...
GlobeNewswire
02-14
Annovis Bio Announces Last Patient Last Visit in the Phase II/III Study of Buntanetap in Alzheimer’s...
GlobeNewswire
01-30
Annovis Bio Announces the Filing of New Patent Application for Treatment of Mental Illnesses Expandi...
GlobeNewswire
2023-12-05
Annovis Bio Announces Last Patient Last Visit in the Phase III Study of Buntanetap in Parkinson’s Di...
GlobeNewswire
2023-11-27
Annovis Bio Announces Full Enrollment of Its Phase II/III Alzheimer’s Disease Trial, Exceeding Origi...
GlobeNewswire
2023-11-08
Annovis Bio Announces Third Quarter 2023 Financial Results and Provides Corporate Update
GlobeNewswire
2023-11-07
US Neurologists Emphasize Tremendous Unmet Treatment Need in Parkinson's Disease, According to Spher...
GlobeNewswire
2023-10-12
Annovis Bio Announces Positive Interim Independent Analysis for Statistical Power in Its Alzheimer’s...
GlobeNewswire
2023-09-21
Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference
Newsfile Corp
2022-05-04
Annovis Bio Announces First Quarter 2022 Results and Provides Corporate Update
Newsfile Corp
2022-04-28
Annovis Bio Announces Cooperative Research and Development Agreement (CRADA) with the National Insti...
Newsfile Corp
2022-04-11
Annovis Bio to Participate in World Parkinson's Day to Raise Awareness on the Debilitating Disease
Newsfile Corp
2022-03-23
Annovis Bio to Present at the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted...
Newsfile Corp
2022-03-18
Annovis Bio Presents at International Conference on Alzheimer's & Parkinson (AD/PD 2022)
Newsfile Corp
2022-03-08
Annovis Bio Announces Presentation at International Conference on Alzheimer's & Parkinson's Diseases...
Newsfile Corp
2022-01-25
Annovis Bio Announces Positive FDA Feedback for Buntanetap Phase 3 Clinical Development in Parkinson...
Newsfile Corp
2022-01-05
Annovis Bio Announces Official Unique Name Buntanetap for Lead Candidate ANVS401
